AtkinsRéalis revised revenue guidance for the full year of 2024. For the year, the company expects Nuclear organic revenue growth outlook for full year 2024 compared to 2023 raised to between 15% and 20%, from the previous range of between 12% and 15%, reflecting strong growth to date and confidence in continued demand, supported by a strong backlog.